Take control of your biologic spending.

Costs for biologic drugs and services are spiraling out of control, and Health Plans and employers are stuck with the bill. Biologic drugs and services can cost up to $400,000 per year per patient and are expected to constitute up to 30 percent of a payor's overall drug spend.

The high costs primarily come from a combination of outpatient hospitals marking up drugs and charging facility fees on top of the high infusion nursing rates. The lack of accountability is a direct result of hidden fees, complex billing statements, and the lack of clinical data supporting the therapy.

ACN provides total control of your biologics spending through a single contracted rate for infusion and injection services and actionable reporting that allows plans to see where and how their members are being cared for.

In addition, ACN is unique in that we help you leverage your existing Specialty Pharmacy relationships. Health Plans achieve significant cost controls through this seamless integration with their current Specialty Pharmacies. Health Plans capture negotiated discounts and rebates, through the shipment of drugs directly to the site of care.

Finally, ACN creates a means to monitor and ensure consistent clinical and plan protocol adherence by enrollees, resulting in improved patient compliance and lower costs down the road.